Related Experiment Video
Updated: Jun 7, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Palmitoylation of platelet proteins
1Department of Biochemistry, SUNY Health Science Center, 450 Clarkson Avenue, Brooklyn, NY, 11203, USA.
Platelets
|November 4, 2010
Summary
Platelet activation involves palmitoylation, a process where palmitic acid attaches to proteins. This modification affects key platelet proteins, influencing their function during activation.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Palmitoylation is a post-translational modification involving the addition of palmitic acid to proteins.
- This process occurs in various cell types, including platelets, and influences protein function and localization.
- Understanding palmitoylation in platelets is crucial for comprehending platelet activation and function.
Purpose of the Study:
- To investigate the occurrence and characteristics of protein palmitoylation in human platelets.
- To identify palmitoylated proteins in platelets and their potential role in platelet activation.
- To explore the effect of platelet activators on protein palmitoylation.
Main Methods:
- Incorporation of radiolabeled palmitic acid ([ (3)H] palmitic acid) into platelet proteins.
- Analysis using SDS-PAGE under reducing and non-reducing conditions.
- Treatment of platelets with activators like thrombin, PMA, and A23187, followed by analysis of label incorporation and protein modification.
Main Results:
- Palmitoylation of platelet proteins was confirmed, with a stable linkage sensitive to hydroxylamine.
- A prominent quadruplet of 30-38 kDa proteins was identified as major palmitoylated targets, appearing as a 38 kDa doublet under reducing conditions.
- Platelet activation by thrombin or PMA enhanced palmitoylation of these proteins, suggesting involvement in activation pathways.
- Specific protein shifts and decreases in label were observed upon stimulation with A23187 and PMA, indicating dynamic regulation.
- Some palmitoylated proteins were associated with the cytoskeleton, with differential effects observed upon thrombin stimulation.
- Identified palmitoylated proteins include CD9, glycoproteins IIIa, Ib, and IX.
Conclusions:
- Palmitoylation is a significant post-translational modification in human platelets, impacting protein function and platelet activation.
- Specific palmitoylated proteins, including CD9 and certain glycoproteins, are involved in platelet signaling and cytoskeletal association.
- Further research into palmitoylated platelet proteins may reveal novel therapeutic targets for platelet-related disorders.
Related Concept Videos
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:32Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...